Cargando…

Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016

BACKGROUND: PrEP, regular use of antiretroviral medications by HIV-negative individuals to prevent new HIV infections, has not been widely adopted by some young, high-risk populations. This study investigated the characteristics and estimated percentage of newly diagnosed HIV-infected individuals in...

Descripción completa

Detalles Bibliográficos
Autores principales: Okoye, Stella, Chang, Man-Huei, Weissman, Sharon, Dufffus, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632182/
http://dx.doi.org/10.1093/ofid/ofx162.040
_version_ 1783269648800677888
author Okoye, Stella
Chang, Man-Huei
Weissman, Sharon
Dufffus, Wayne
author_facet Okoye, Stella
Chang, Man-Huei
Weissman, Sharon
Dufffus, Wayne
author_sort Okoye, Stella
collection PubMed
description BACKGROUND: PrEP, regular use of antiretroviral medications by HIV-negative individuals to prevent new HIV infections, has not been widely adopted by some young, high-risk populations. This study investigated the characteristics and estimated percentage of newly diagnosed HIV-infected individuals in South Carolina (SC) who had visited a health care facility (HCF) while HIV-negative and missed opportunities for initiating PrEP. METHODS: We used a unique person-level identifier to link case reports from the SC enhanced HIV/AIDS Reporting System and records from a statewide all payer HCF database. The HCF data include inpatient (IP), outpatient (OP), and emergency department (ED) visits to SC facilities. Because the Food and Drug Administration approved PrEP in 2012, we analyzed data for individuals diagnosed with HIV during January 2013–September 2016 with initial CD4 count ≥500 cells (recent infection) and HC visits during 2011 through the date of diagnosis. We used the two-tailed chi-square statistics with a significant threshold of P < 0.05 in SAS to investigate the association between the absence of a PrEP prescription and patient factors including demographics, behavioral risk, visit setting (IP, OP or ED), frequency of previous visits, and residence at diagnosis. RESULTS: A total of 785 patients were diagnosed with recent HIV infections (initial CD4 ≥500 cell) during January 2013–September 2016. Of these, 504 (64.2%) visited an SC HCF at least once before being diagnosed, 72.4% were males, 52.4% aged <30 years, 54% were men who have sex with men (MSM) or injection drug users (IDU) and 70.2% resided in urban areas. Mean number of HCF visits before HIV diagnosis was 6.6; 84.3% had ED visits; 5.9% had IP visits; and 7.0% had OP visits. Persons of female sex, Black race, younger age and urban residence were more likely to access HCF visit before HIV diagnosis (P < 0.05). CONCLUSION: We now know the characteristics and percentage (64.2%) of persons with recent HIV infections captured in two large state-wide databases in SC who missed opportunities to be screened and initiated PrEP during visits to HCFs before HIV diagnosis during 2013–2016. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632182
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56321822017-11-07 Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016 Okoye, Stella Chang, Man-Huei Weissman, Sharon Dufffus, Wayne Open Forum Infect Dis Abstracts BACKGROUND: PrEP, regular use of antiretroviral medications by HIV-negative individuals to prevent new HIV infections, has not been widely adopted by some young, high-risk populations. This study investigated the characteristics and estimated percentage of newly diagnosed HIV-infected individuals in South Carolina (SC) who had visited a health care facility (HCF) while HIV-negative and missed opportunities for initiating PrEP. METHODS: We used a unique person-level identifier to link case reports from the SC enhanced HIV/AIDS Reporting System and records from a statewide all payer HCF database. The HCF data include inpatient (IP), outpatient (OP), and emergency department (ED) visits to SC facilities. Because the Food and Drug Administration approved PrEP in 2012, we analyzed data for individuals diagnosed with HIV during January 2013–September 2016 with initial CD4 count ≥500 cells (recent infection) and HC visits during 2011 through the date of diagnosis. We used the two-tailed chi-square statistics with a significant threshold of P < 0.05 in SAS to investigate the association between the absence of a PrEP prescription and patient factors including demographics, behavioral risk, visit setting (IP, OP or ED), frequency of previous visits, and residence at diagnosis. RESULTS: A total of 785 patients were diagnosed with recent HIV infections (initial CD4 ≥500 cell) during January 2013–September 2016. Of these, 504 (64.2%) visited an SC HCF at least once before being diagnosed, 72.4% were males, 52.4% aged <30 years, 54% were men who have sex with men (MSM) or injection drug users (IDU) and 70.2% resided in urban areas. Mean number of HCF visits before HIV diagnosis was 6.6; 84.3% had ED visits; 5.9% had IP visits; and 7.0% had OP visits. Persons of female sex, Black race, younger age and urban residence were more likely to access HCF visit before HIV diagnosis (P < 0.05). CONCLUSION: We now know the characteristics and percentage (64.2%) of persons with recent HIV infections captured in two large state-wide databases in SC who missed opportunities to be screened and initiated PrEP during visits to HCFs before HIV diagnosis during 2013–2016. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632182/ http://dx.doi.org/10.1093/ofid/ofx162.040 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Okoye, Stella
Chang, Man-Huei
Weissman, Sharon
Dufffus, Wayne
Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title_full Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title_fullStr Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title_full_unstemmed Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title_short Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
title_sort missed opportunities to initiate pre-exposure prophylaxis in south carolina—2013–2016
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632182/
http://dx.doi.org/10.1093/ofid/ofx162.040
work_keys_str_mv AT okoyestella missedopportunitiestoinitiatepreexposureprophylaxisinsouthcarolina20132016
AT changmanhuei missedopportunitiestoinitiatepreexposureprophylaxisinsouthcarolina20132016
AT weissmansharon missedopportunitiestoinitiatepreexposureprophylaxisinsouthcarolina20132016
AT dufffuswayne missedopportunitiestoinitiatepreexposureprophylaxisinsouthcarolina20132016